Get the SPI Wire

Citius Oncology, Inc.

NASDAQ:CTOR
Annual Meeting

of Shareholders

MEETING DATE

09/29/2026
DEF 14A FILED
08/26/2026
PUBLISHED
08/26/2026 1:00 pm
TIME TO PUBLISH
08/28/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CTOR · CUSIP 17331Y109 · CLASS common stock · CIK 0001851484

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
0
AGAINST
0
WITHHOLD
2
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated Dr. Holuka, Mr. Smith and Ms. Webb, and each nominee consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of the selection of Wolf & Company, P.C., an independent registered public accounting firm, as the auditor of the Company for the fiscal year ending September 30, 2026
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit and Risk Committee discussed Wolf's independence and pre-approved all reported fees.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

514b0d1dd1a72099e7cceeadac3899c967680217b0ae3651f3fae916ec767e3d

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates